Literature DB >> 1309302

The clinical and histologic criteria that predict metastases from cystosarcoma phyllodes.

R E Hawkins1, J B Schofield, C Fisher, E Wiltshaw, J A McKinna.   

Abstract

A retrospective study of 33 patients with cystosarcoma phyllodes was done. Eight of these patients had metastases, and the clinical and histologic criteria predicting the development of metastases were examined. The most reliable predictor was the presence of stromal overgrowth; this appears to be necessary for metastasis to occur. Other useful indicators of clinical behavior were the degree of mitotic activity, nuclear pleomorphism, and infiltrating margins. Based on these data and a literature review, the authors suggest close follow-up of patients whose primary tumors contain areas of stromal overgrowth because, in all series combined, the risk of metastatic spread in such patients was 72% within 5 years. Among these high-risk patients, local recurrence is another indication that metastasis is likely.

Entities:  

Mesh:

Year:  1992        PMID: 1309302     DOI: 10.1002/1097-0142(19920101)69:1<141::aid-cncr2820690125>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  30 in total

1.  Phyllodes Tumor of the Breast: Pathology, Histogenesis, Diagnosis, and Treatment.

Authors: 
Journal:  Breast Cancer       Date:  1996-06-28       Impact factor: 4.239

2.  The clinical features and prognosis of phyllodes tumors: a single institution experience in Taiwan.

Authors:  Chin-Chan Lin; Hui-Wen Chang; Chen-Yuan Lin; Chang-Fang Chiu; Shin-Pen Yeh
Journal:  Int J Clin Oncol       Date:  2012-07-07       Impact factor: 3.402

Review 3.  Phyllodes tumors of the breast: diagnosis, treatment and prognostic factors related to recurrence.

Authors:  Zhi-Rui Zhou; Chen-Chen Wang; Zhao-Zhi Yang; Xiao-Li Yu; Xiao-Mao Guo
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

4.  Unusually large breast tumour in a middle-aged woman.

Authors:  Rumi Khajotia; Sangeetha Poovaneswaran; Thamilselvam Pavadai; Subathra Sabaratnam; Hanizah Khairan
Journal:  Can Fam Physician       Date:  2014-02       Impact factor: 3.275

5.  Size and heterologous elements predict metastases in malignant phyllodes tumours of the breast.

Authors:  Valerie Cui Yun Koh; Aye Aye Thike; Nur Diyana Md Nasir; George Wai Cheong Yip; Boon Huat Bay; Puay Hoon Tan
Journal:  Virchows Arch       Date:  2017-11-10       Impact factor: 4.064

6.  Ubiquitin carboxy-terminal hydrolase L1 may be involved in the development of mammary phyllodes tumors.

Authors:  Huang-Chun Lien; Chung-Chieh Wang; Chiun-Sheng Huang; Ya-Wen Yang; Wen-Hung Kuo; Yu-Tung Yao
Journal:  Virchows Arch       Date:  2013-01-05       Impact factor: 4.064

Review 7.  Phyllodes tumours.

Authors:  S J Parker; S A Harries
Journal:  Postgrad Med J       Date:  2001-07       Impact factor: 2.401

8.  Diagnosis and management of phyllodes tumour of the breast: experience of 33 cases at a specialist centre.

Authors:  J F Stebbing; A G Nash
Journal:  Ann R Coll Surg Engl       Date:  1995-05       Impact factor: 1.891

9.  A Case of Pleuroparenchymal Metastasis: Rare Aetiology.

Authors:  Subramanian Suriyan; Radhika Sharma; Meenakshi Narasimhan; Aruna Shanmuganathan; Adhithyan Rajendran
Journal:  J Clin Diagn Res       Date:  2016-04-01

10.  Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity.

Authors:  Su-Yang Liu; Nancy M Joseph; Ajay Ravindranathan; Bradley A Stohr; Nancy Y Greenland; Poonam Vohra; Elizabeth Hosfield; Iwei Yeh; Eric Talevich; Courtney Onodera; Jessica A Van Ziffle; James P Grenert; Boris C Bastian; Yunn-Yi Chen; Gregor Krings
Journal:  Mod Pathol       Date:  2016-06-03       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.